1. FDA grants priority review to Roche's lung cancer drug Tecentriq — Teva drug fails in pediatric Tourette syndrome trial — GSK pays $50M for two solid tumor cell therapies from Immatics — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Should J&J owe billions for Oklahoma's opioid crisis? We'll find out Monday

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 23, 2019 at 12:22 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    14,106
    Likes Received:
    3
    via Opioid drugmakers face thousands of lawsuits around the country, a mountain of them grouped in Cleveland’s federal court. But right now, it's a Monday decision—in the first opioid case to make it to trial nationally—that has market watchers bracing for news.

    article source